中文名 | 1-乙酰基-4-(2-羟基乙基)哌嗪盐酸盐 |
---|---|
英文名 | 1-[4-(2-hydroxyethyl)piperazin-1-yl]ethanone,hydrochloride |
中文别名 |
1-乙酰基-4-(2-羟基乙基)-哌嗪盐酸盐
1-[4-(2-羟乙基)-1-哌嗪基]乙酮 |
英文别名 |
1-[4-(2-hydroxyethyl)-1-piperazinyl]-1-ethanone
1-Acetyl-4-(2-hydroxyethyl)piperazine 1-(4-(2-hydroxyethyl)piperazin-1-yl)ethanone hydrochloride 1-Acetyl-4-(2-hydroxyethyl)piperazine hydrochloride 1-[4-(2-Hydroxyethyl)-1-piperazinyl]ethanone 1-(2-hydroxyethyl)-4-acetylpiperazine 2-(4-acetylpiperazino)ethanol 1-[4-(2-hydroxy-ethyl)piperazin-1-yl]ethanone 4-acetyl-1-(hydroxylethyl)piperazine |
密度 | 1.111 g/cm3 |
---|---|
沸点 | 367ºC at 760 mmHg |
分子式 | C8H17ClN2O2 |
分子量 | 208.68600 |
闪点 | 175.7ºC |
精确质量 | 208.09800 |
PSA | 43.78000 |
储存条件 | 室温,干燥 |
海关编码 | 2933599090 |
---|
~74% 83502-55-0 |
文献:PFIZER LIMITED; PFIZER INC. Patent: WO2005/82866 A2, 2005 ; Location in patent: Page/Page column 99-100 ; WO 2005/082866 A2 |
~65% 83502-55-0 |
文献:AstraZeneca AB Patent: US6559143 B1, 2003 ; US 6559143 B1 |
~53% 83502-55-0 |
文献:JE IL PHARMACEUTICAL CO., LTD. Patent: WO2007/102679 A1, 2007 ; Location in patent: Page/Page column 109-110 ; WO 2007/102679 A1 |
~% 83502-55-0 |
文献:Journal of Organic Chemistry, , vol. 54, # 9 p. 2153 - 2159 |
~% 83502-55-0 |
文献:Journal of Organic Chemistry, , vol. 54, # 9 p. 2153 - 2159 |
~% 83502-55-0 |
文献:Journal of Organic Chemistry, , vol. 55, # 5 p. 1676 - 1679 |
~% 83502-55-0 |
文献:International Journal of Chemical Kinetics, , vol. 43, # 12 p. 687 - 693 |
~% 83502-55-0 |
文献:International Journal of Chemical Kinetics, , vol. 43, # 12 p. 687 - 693 |
~% 83502-55-0 |
文献:International Journal of Chemical Kinetics, , vol. 43, # 12 p. 687 - 693 |
海关编码 | 2933599090 |
---|---|
中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |